Intelligent bio solutions inc. announces pricing of $2.2 million public offering

New york, march 08, 2023 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (the “company”), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced the pricing of its previously announced underwritten public offering of 569,560 shares of common stock and warrants to purchase up to 170,868 shares of its common stock at a combined public offering price of $3.90 per share of common stock and accompanying warrants, for initial gross proceeds of approximately $2.2 million, before underwriting discounts and commissions and offering expenses. the warrants have an exercise price of $3.90 per share, are exercisable immediately and will expire five years following the date of issuance.
INBS Ratings Summary
INBS Quant Ranking